Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20251 - 20275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	ZNF557	79230	upregulated	cupric oxide results in increased expression of ZNF557 mRNA	19p13.2	A21783
Cupric oxide	Approved	ZNF558	148156	upregulated	cupric oxide results in increased expression of ZNF558 mRNA	19p13.2	A21783
Cupric oxide	Approved	ZNF565	147929	upregulated	cupric oxide results in increased expression of ZNF565 mRNA	19q13.12	A21783
Cupric oxide	Approved	ZNF625	90589	upregulated	cupric oxide results in increased expression of ZNF625 mRNA	19p13.2	A21783
Cupric oxide	Approved	ZNF626	199777	upregulated	cupric oxide results in increased expression of ZNF626 mRNA	19p12	A21783
Cupric oxide	Approved	ZNF669	79862	upregulated	cupric oxide results in increased expression of ZNF669 mRNA	1q44	A21783
Cupric oxide	Approved	ZNF707	286075	upregulated	cupric oxide results in increased expression of ZNF707 mRNA	8q24.3	A21783
Cupric oxide	Approved	ZNF721	170960	upregulated	cupric oxide results in increased expression of ZNF721 mRNA	4p16.3	A21783
Cupric oxide	Approved	ZNF780B	163131	upregulated	cupric oxide results in increased expression of ZNF780B mRNA	19q13.2	A21783
Cupric oxide	Approved	ZNF79	7633	upregulated	cupric oxide results in increased expression of ZNF79 mRNA	9q33.3	A21783
Cupric oxide	Approved	ZNF8	7554	upregulated	cupric oxide results in increased expression of ZNF8 mRNA	19q13.43	A21783
Cupric oxide	Approved	ZRANB2	9406	upregulated	cupric oxide results in increased expression of ZRANB2 mRNA	1p31.1	A21783
Cupric oxide	Approved	ZRSR2	8233	upregulated	cupric oxide results in increased expression of ZRSR2 mRNA	Xp22.2	A21783
Cupric oxide	Approved	ZSCAN2	54993	upregulated	cupric oxide results in increased expression of ZSCAN2 mRNA	15q25.2	A21783
Cupric oxide	Approved	ZSCAN20	7579	upregulated	cupric oxide results in increased expression of ZSCAN20 mRNA	1p35.1	A21783
Curcumin	Approved Investigational	AARS	16	downregulated	Curcumin results in decreased expression of AARS mRNA	16q22.1	A21786
Curcumin	Approved Investigational	ABCB1	5243	downregulated	Curcumin results in decreased expression of ABCB1 mRNA	7q21.12	A21787 A21788 A21789
Curcumin	Approved Investigational	ABCC1	4363	downregulated	Curcumin analog results in decreased expression of ABCC1 mRNA	16p13.11	A21790
Curcumin	Approved Investigational	ABCG1	9619	upregulated	Curcumin results in increased expression of ABCG1 mRNA	21q22.3	A21791 A21792
Curcumin	Approved Investigational	ACKR3	57007	upregulated	Curcumin results in increased expression of ACKR3 mRNA	2q37.3	A21792
Curcumin	Approved Investigational	ADAMTS4	9507	upregulated	Curcumin results in increased expression of ADAMTS4 mRNA	1q23.3	A21793
Curcumin	Approved Investigational	ADCY9	115	downregulated	Curcumin results in decreased expression of ADCY9 mRNA	16p13.3	A21794
Curcumin	Approved Investigational	AGR2	10551	downregulated	Curcumin results in decreased expression of AGR2 mRNA	7p21.1	A21786
Curcumin	Approved Investigational	AKAP6	9472	upregulated	Curcumin results in increased expression of AKAP6 mRNA	14q12	A21795
Curcumin	Approved Investigational	AKT1	207	downregulated	Curcumin analog results in decreased expression of AKT1 mRNA	14q32.33	A21790

Displaying entries 20251 - 20275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability